Global Market Reach Occlutech’s devices are sold to hospitals and clinics across over 80 countries, demonstrating extensive international presence that presents multiple regional sales opportunities within diverse healthcare markets.

Expanding Product Pipeline Recent launches such as the AFR device for heart failure and ongoing pivotal US studies indicate strong growth momentum, offering opportunities to engage with hospitals seeking innovative minimally invasive cardiac solutions.

Strategic Partnerships Partnerships like the exclusive distribution agreement with B. Braun Interventional Systems in the US highlight potential channels for expanding reach and sales through established medical distribution networks.

Leadership & Growth Focus The appointment of new leadership, including a new Chairman and key executives in regulatory and clinical roles, signals a focus on strategic expansion and regulatory approval pathways, creating opportunities to align sales efforts with upcoming product approvals.

Financial Stability & Potential With revenues estimated between $50M to $100M and a recent acquisition plan by Alkem MedTech, there is potential for increased investment in sales initiatives and expanded market penetration as the company scales operations.